Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen M Hewitt

Showing results (271-280 of 413) with videos related to

Pageof 42
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancerDonal J Brennan, Elton Rexhepaj, Sallyann L O'Brien, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 3, 2002
Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndromeBerton Zbar, W Gregory Alvord, Gladys Glenn, et al.
Journal of the Endocrine Society|September 16, 2022
Precocious Puberty in a Boy With Bilateral Leydig Cell Tumors due to a Somatic Gain-of-Function <i>LHCGR</i> VariantChelsi Flippo, Vipula Kolli, Melissa Andrew, et al.
Cancer Biomarkers : Section a of Disease Markers|February 19, 2010
Analysis of the expression of human tumor antigens in ovarian cancer tissuesRouba Ali-Fehmi, Madhumita Chatterjee, Alexei Ionan, et al.
The Journal of Clinical Investigation|October 25, 2012
Nanog signaling in cancer promotes stem-like phenotype and immune evasionKyung Hee Noh, Bo Wook Kim, Kwon-Ho Song, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 29, 2014
PLCE1 mRNA and protein expression and survival of patients with esophageal squamous cell carcinoma and gastric adenocarcinomaWen-Qing Li, Nan Hu, Victoria H Burton, et al.
Breast Cancer Research and Treatment|January 14, 2016
The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and AxlJennifer L Dine, Ciara C O'Sullivan, Donna Voeller, et al.
Scientific Reports|July 28, 2017
The anti-cancer effects of itraconazole in epithelial ovarian cancerChel Hun Choi, Ji-Yoon Ryu, Young-Jae Cho, et al.
Cancer Research|October 31, 2007
Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based studyXiaohong R Yang, Ruth M Pfeiffer, Montserrat Garcia-Closas, et al.
International Journal of Cancer|December 20, 2018
Relationship of DNA methylation to mutational changes and transcriptional organization in fusion-positive and fusion-negative rhabdomyosarcomaWenyue Sun, Bishwanath Chatterjee, Jack F Shern, et al.
Pageof 42

Showing results (271-280 of 413) with videos related to

Sort By:
Pageof 42
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancerDonal J Brennan, Elton Rexhepaj, Sallyann L O'Brien, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 3, 2002
Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndromeBerton Zbar, W Gregory Alvord, Gladys Glenn, et al.
Journal of the Endocrine Society|September 16, 2022
Precocious Puberty in a Boy With Bilateral Leydig Cell Tumors due to a Somatic Gain-of-Function <i>LHCGR</i> VariantChelsi Flippo, Vipula Kolli, Melissa Andrew, et al.
Cancer Biomarkers : Section a of Disease Markers|February 19, 2010
Analysis of the expression of human tumor antigens in ovarian cancer tissuesRouba Ali-Fehmi, Madhumita Chatterjee, Alexei Ionan, et al.
The Journal of Clinical Investigation|October 25, 2012
Nanog signaling in cancer promotes stem-like phenotype and immune evasionKyung Hee Noh, Bo Wook Kim, Kwon-Ho Song, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 29, 2014
PLCE1 mRNA and protein expression and survival of patients with esophageal squamous cell carcinoma and gastric adenocarcinomaWen-Qing Li, Nan Hu, Victoria H Burton, et al.
Breast Cancer Research and Treatment|January 14, 2016
The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and AxlJennifer L Dine, Ciara C O'Sullivan, Donna Voeller, et al.
Scientific Reports|July 28, 2017
The anti-cancer effects of itraconazole in epithelial ovarian cancerChel Hun Choi, Ji-Yoon Ryu, Young-Jae Cho, et al.
Cancer Research|October 31, 2007
Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based studyXiaohong R Yang, Ruth M Pfeiffer, Montserrat Garcia-Closas, et al.
International Journal of Cancer|December 20, 2018
Relationship of DNA methylation to mutational changes and transcriptional organization in fusion-positive and fusion-negative rhabdomyosarcomaWenyue Sun, Bishwanath Chatterjee, Jack F Shern, et al.
Pageof 42